ADVANCED SYSTEMIC MASTOCYTOSIS
Clinical trials for ADVANCED SYSTEMIC MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SYSTEMIC MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for ADVANCED SYSTEMIC MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: experimental drug MGD024 enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called MGD024 in people with certain blood cancers (like leukemia and lymphoma) that came back or didn't get better with standard treatments. The main goal is to find the safest dose and watch for side effects. About 130 adults will receive…
Matched conditions: ADVANCED SYSTEMIC MASTOCYTOSIS
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for rare blood cancer: experimental drug targets mast cells
Disease control Recruiting nowThis study tests an experimental drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by blocking a key protein that drives abnormal mast cell growth. About 140 adults with aggre…
Matched conditions: ADVANCED SYSTEMIC MASTOCYTOSIS
Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC